Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gynecologic Oncology

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/GYNO.2001.6120PMID 11330940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of procathepsin D activation peptide in prostate cancer growth

  2000cited by this paper
• Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview.

  2000cited by this paper
• Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.

  1999cited by this paper
• Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients

  1998cited by this paper
• Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.

  1997cited by this paper
• Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro‐cathepsin D immunoassay

  1997cited by this paper
• Immunologic characterization of tumor markers in human ovarian cancer cell lines.

  1996cited by this paper
• Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

  1996cited by this paper
• Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis

  1996cited by this paper
• Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients.

  1995cited by this paper
• Prognostic Significance of Autoantibodies to Laminin in the Sera of Breast Cancer Patients: A Preliminary Report

  1994cited by this paper
• Antigens and antibodies in malignant melanoma.

  1994cited by this paper
• Increased accumulation of p53 protein in cisplatin‐resistant ovarian cell lines

  1993cited by this paper
• Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.

  1989cited by this paper
• In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.

  1988cited by this paper
• “Membrane‐Associated” Immunoglobulins in Cyst and Ascites Fluids of Ovarian Cancer Patients *

  1983cited by this paper
• Isolation of plasma membrane fragments from cultured murine melanoma cells.

  1983cited by this paper
• Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments.

  1980cited by this paper
• Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography.

  1979cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Role of lysosomes in physiological activities, diseases, and therapy

  2021cites this paper
• Screening Combinatorial Peptide Libraries in Protease Inhibitor Drug Discovery

  2018cites this paper
• In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine Cancer

  2015cites this paper
• Proteomic identification of dihydrolipoamide dehydrogenase as a target of autoantibodies in patients with endometrial cancer.

  2014cites this paper
• Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.

  2012cites this paper
• Epidemiologic perspective on immune-surveillance in cancer.

  2011cites this paper
• Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.

  2009cites this paper
• Immunomodulation in Endometrial Cancer

  2008cites this paper
• Autoantibody to Tumor Antigen, Alpha 2-HS Glycoprotein: A Novel Biomarker of Breast Cancer Screening and Diagnosis

  2008cites this paper
• Autoantibodies, Autoimmunity, and Cancers

  2004cites this paper
• Non‐self‐discrimination as a driving concept in the identification of an immunodominant HMW‐MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients

  2004cites this paper